(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of 1.09% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.88%.
Embecta's revenue in 2025 is $1,079,500,000.On average, 6 Wall Street analysts forecast EMBC's revenue for 2026 to be $64,520,528,832, with the lowest EMBC revenue forecast at $61,773,730,956, and the highest EMBC revenue forecast at $66,566,016,612. On average, 5 Wall Street analysts forecast EMBC's revenue for 2027 to be $64,871,183,880, with the lowest EMBC revenue forecast at $62,241,271,020, and the highest EMBC revenue forecast at $66,916,671,660.
In 2028, EMBC is forecast to generate $65,163,396,420 in revenue, with the lowest revenue forecast at $62,241,271,020 and the highest revenue forecast at $67,501,096,740.